Record Revenue and Earnings
Q1 revenue of $1.282 billion (Greg referenced ~ $1.3B) and non-GAAP EPS of $2.56, both above the high end of guidance. Total company sales were up 87% year-over-year and 18% sequentially; non-GAAP EPS was up 241% year-over-year and 42% sequentially.
Semiconductor Test Breaks $1B
Semi Test revenue reached $1.1 billion for the quarter (first time over $1B), up 26% sequentially and more than 100% year-over-year. SoC represented $882M, memory $203M and IST $27M.
Strong Margins and Operating Profit
Gross margin of 60.9%, a record and up ~370 basis points sequentially. Non-GAAP operating income was $480M with an operating margin of 37.5%, both all-time records.
AI Demand Driving Mix Shift
AI-related demand accounted for nearly 70% of revenue in Q1 (up from ~60% in Q4 2025). Management attributes the record results to durable AI demand and execution on the wafer-to-AI data center strategy.
Product Momentum — Memory, Robotics, Product Test
Memory revenue $203M (robust HBM and DRAM demand; Magnum 7 ramped). Robotics revenue $91M, up 32% year-over-year and fourth consecutive quarter of sequential growth. Product Test revenue $80M, up 8% year-over-year.
New Product Introductions
Two significant new products launched in Q1: Photon 100 (silicon photonics / co-packaged optics test platform) targeting a potential midterm TAM of $300M–$700M, and Omnyx (production board test platform to detect defects earlier in AI data center builds).
Merchant GPU Production Win and Pipeline
Received first multi-system production test orders for merchant GPU in Q1; systems expected to ship, be installed and be in production in Q2. Line of sight to about $50M of merchant GPU revenue for the year; pipeline of additional design wins remains robust.
Strategic M&A and Partnerships
Closed MultiLane Test Products joint venture (April 8) and acquired TestInsight (April 16) to strengthen high-speed I/O/data center interconnect test solutions and test development tools. Combined deals used ~ $165M of cash (funded via credit revolver).
Operational Execution and Capacity
More than doubled UltraFLEXplus shipments over 9 months while maintaining 12–16 week lead times; cash & investments ~ $400M; capital expenditure flat YoY with expected increase in Q2 to support scaling.